Jetron, a next-generation white bio manufacturing company, announced on the 23rd that it had secured seed investment from Bluepoint. The specific investment amount and company value were not disclosed.
Jetron is developing an efficient biochemical manufacturing process by integrating low-temperature plasma (LTP), synthetic biology (SynBio), and artificial intelligence (AI) technologies. A notable feature is its ability to overcome the energy barrier of existing white bio processes using low-temperature plasma technology.
Just six months after its founding, Jetron successfully developed a proprietary platform technology that controls microbial fermentation without physical electrodes. This technology is expected to address yield limitations, electrode contamination, and cost issues in the biomanufacturing industry.
Furthermore, Jetron is pursuing a strategy to utilize microorganisms based on national biological resources to address the issues of dependence on overseas genetic resources and intellectual property (IP) restrictions. This strategy is also considered significant in terms of strengthening national biosecurity.
Bluepoint decided to invest in this company because it highly values CEO Cho In-jin's technological prowess and execution capabilities, as well as the significant growth potential of the white bio industry. The global white bio market is projected to grow at an average annual rate of over 10%, reaching $560.9 billion (approximately KRW 802 trillion) by 2028.
“Jetron has the potential to transform the existing bio-manufacturing paradigm,” said Min Nam-ki, Bluepoint’s senior review officer. “We will continue to support Jetron in realizing its vision of a self-circulating, decarbonized bio-refinery.”
“We will lead the decarbonization era based on the Net-Zero Energram,” said Jetron CEO Cho In-jin. “By combining LTP-SynBio-AI technology with national biological resources, we will contribute to solving the global problem of sustainable fuel and chemical product production.”
Meanwhile, Jetron plans to use this investment to expand its core R&D workforce and pursue follow-up partnerships to maximize the economic viability of its platform technology.
- See more related articles
You must be logged in to post a comment.